Ananta Addala

Ananta Addala, DO, Assistant Professor, Department of Pediatrics -Endocrinology and Diabetes, Stanford University School of Medicine 

Research Description: Dr. Ananta Addala is a pediatric endocrinologist and physician scientist at Stanford University addressing disparities in pediatric type 1 diabetes management and outcomes. As a physician with a background in pediatric endocrinology, epidemiology, and behavioral health, she aims to build an evidence-based approach to addressing T1D disparities by systematically evaluating youth-, family-, provider-, and system-level barriers to optimal diabetes care in youth from low socioeconomic and racial/ethnic minority groups. 

She is funded by NIDDK K23 to understand and address disparities in pediatric diabetes technology access and utilization. She also has funding from the Maternal Child Research Institute and Helmsley Charitable Trust. To date, her publications have demonstrated that the disparities in pediatric T1D by socioeconomic status are worsening in the US, provider bias against public insurance is common, and public insurance mediated interruptions to diabetes technology adversely impact glycemic outcomes. She has also been leading the efforts to improve justice, equity, diversity, and inclusion in research at Stanford University through her leadership at Stanford Pediatrics Advancing Anti-Racism Coalition and as the co-chair of TrialNet's Underrepresented Minorities Outreach Committee.

Selected relevant publications (Stanford DRC members are in BOLD, note #5 is an abstract with a manuscript under review)

  1. Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK. Provider Implicit Bias Impacts Pediatric Type 1 Diabetes Technology Recommendations in the United States: Findings from The Gatekeeper Study. J Diabetes Sci Technol. 2021 Apr 15:19322968211006476. doi: 10.1177/19322968211006476. Epub ahead of print. PMID: 33858206.

  2. Addala A, Auzanneau M, Miller K, Maier W, Foster N, Kapellen T, Walker A, Rosenbauer J, Maahs DM, Holl RW. A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Trans-Atlantic Comparison. Diabetes Care 2020 Sep. PMID: 32938745.

  3. Addala A, Maahs DM, Scheinker D, Chertow S, Leverenz B, Prahalad P. Uninterrupted Continuous Glucose Monitoring Access is Associated with a Decrease in HbA1c in Youth with Type 1 Diabetes and Public Insurance. Pediatr Diabetes. 2020 Jul 17. PMID: 32681582.

  4.  Addala A, Chan RY, Vargas J, Weigensberg MJ. Global Well-Being is Associated with A1c and Frequency of Self-Monitoring of Blood Glucose in Predominantly Latinx Youth and Young Adults with Type 1 Diabetes. Diabetes Spectrum. December 21, 2020. doi: 10.2337/ds20-0041.

  5. Addala A, Roque X, Figg L, Anez-Zabala C, Clark C, Lal RA, Haller MJ, Maahs DM, Walker, AF; 262-OR: Recruiting Historically Underrepresented Individuals into Clinical Trials: Key Lessons from Project ECHO Diabetes. Diabetes 1 June 2022; 71 (Supplement_1): 262–OR. https://doi.org/10.2337/db22-262-OR.